远程缺血预适应减轻肝切除术后缺血再灌注损伤:一项随机假手术对照试验
这项随机、对照、三盲单中心试验纳入102例慢性肝病并计划行肝切除术的患者,于2019年12月至2022年3月入组,随机分为远程缺血预适应组与假手术组,各51例。远程缺血预适应采用上肢3个10分钟循环的交替缺血与再灌注。主要终点术后第1天转氨酶在两组间无显著差异,临床结局与生物标志物水平也相当。
要点
- 远程缺血预适应组与假手术组术后第1天转氨酶无显著差异(P=.820/0.639)。
- 两组临床结局及远程缺血预适应生物标志物水平相当。
- 远程缺血预适应采用上肢3个10分钟循环的交替缺血与再灌注。
核心结论
- 远程缺血预适应未显著降低术后转氨酶水平,也未影响临床结果和生物标志物。
研究设计与样本
- 随机、对照、三盲单中心试验,2019年12月至2022年3月共纳入102例慢性肝病并计划行肝切除术的患者,随机分为远程缺血预适应组与假手术组,每组51例;远程缺血预适应通过上肢3个10分钟循环的交替缺血与再灌注诱导;研究前瞻性注册于德国临床试验注册中心(DRKS00018931)。
主要发现
- 患者中位年龄69.5岁,男性69/102(67.7%),平均体重指数25.6 kg/m2。
- 美国麻醉医师协会分级II级55/102(53.9%)、III级45/102(44.1%)。
- 主要终点术后第1天转氨酶:远程缺血预适应组丙氨酸氨基转移酶250(35-1721)U/L、天冬氨酸氨基转移酶320(42-1525)U/L,假手术对照组分别为283(32-792)U/L、356(20-1851)U/L,P=.820/0.639。
- 两组临床结局及远程缺血预适应生物标志物水平相当。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Remote ischemic preconditioning reduces ischemia-reperfusion injury in patients undergoing hepatectomy. Moreover, there is evidence that the protective effects of remote ischemic preconditioning may be more pronounced in pre-damaged livers. The objective of this trial was to investigate the extent to which remote ischemic preconditioning can attenuate ischemia-reperfusion injury after hepatectomy and Pringle maneuver in patients with chronic liver disease. METHODS: In this randomized, controlled, triple-blind monocenter trial, a total of 102 patients with chronic liver disease and planned hepatectomy were enrolled between December 2019 and March 2022. Eligible patients were randomized to the remote ischemic preconditioning or sham arms. Remote ischemic preconditioning was induced through 3 10-minute cycles of alternating ischemia and reperfusion of the upper extremity. The study was prospectively registered in the German Clinical Trials Registry (DRKS00018931). RESULTS: A total of 102 patients were included in the study and were randomized (51 per arm). The median age was 69.5 years, approximately two-thirds of the patients were male (69/102, 67.7%), and the mean body mass index was 25.6 kg/m2. Most patients were classified as American Society of Anesthesiologists II (55/102, 53.9%) or III (45/102, 44.1%). The primary endpoint, the transaminases on the first postoperative day (alanine aminotransferase /aspartate aminotransferase: remote ischemic preconditioning arm: 250 (35-1721)/320 (42-1525) U/L versus sham control arm: 283 (32-792)/356 (20-1851) U/L, P = .820/0.639), clinical outcomes as well as remote ischemic preconditioning biomarker levels were comparable between both arms. CONCLUSION: Remote ischemic preconditioning did not achieve a significant reduction in postoperative transaminase levels, nor did it affect clinical results and biomarkers.
引用
- Hardt JLS, Pohlmann P, Reissfelder C, et al. Remote ischemic preconditioning for reduction of ischemia-reperfusion injury after hepatectomy: A randomized sham-controlled trial. Surgery. 2023. PMID: 37951812. doi:10.1016/j.surg.2023.09.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。